Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02149082 · ClinicalTrials.gov registry record
Near-infrared Spectroscopy (NIRS) for Intracranial Hematoma Detection in Children
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 465
- Enrollment target
NCT02149082 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 465 participants.
The verdict
NCT02149082 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 465 participants
- Enrollment target
Study Summary
This is a study to determine whether the Near infrared spectroscopy (NIRS) optical density (OD) measurement with an Infrascanner device accurately identifies the presence of an intracranial hematoma in pediatric patients ≤18 years of age after known or suspected traumatic brain injury compared with head computerized tomography (CT) scans as the gold standard.
Interventions
- DEVICE Infrascanner Model 2000
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 465 participants |
| Start Date | 2014-06 |
| Est. Completion | 2018-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02149082
The ClinicalTrials.gov registry entry for NCT02149082 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 465 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Infrascanner Model 2000 is the first listed.
NCT02149082 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02149082 about?
NCT02149082 is a clinical study titled "Near-infrared Spectroscopy (NIRS) for Intracranial Hematoma Detection in Children". This is a study to determine whether the Near infrared spectroscopy (NIRS) optical density (OD) measurement with an Infrascanner device accurately identifies the presence of an intracranial hematoma in pediatric patients ≤18 years of age after known or suspected traumatic brain injury compared with ...
What is the current status of trial NCT02149082?
This trial is currently completed. The enrollment target is 465 participants. The study started on 2014-06. Estimated completion is 2018-09.
What interventions are being tested in trial NCT02149082?
The interventions under investigation include: Infrascanner Model 2000 (DEVICE).
Who is sponsoring clinical trial NCT02149082?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.